BTG3 and depressive symptom measurement: During a mean follow-up interval of 14 weeks, the severity of fatigue and daytime sleepiness remained stable in the majority of patients but decreased in a relatively small number of patients, whereas the severity of depression became less severe in most patients during that period. The frequency of elevated ferritin and ANA values in PCS patients is markedly increased, even months after COVID-19 infection.